STAT

Testing for Zika virus in blood donors finds few infections — at a cost of about $5.3 million each

The screening cost works out to about $5.3 million for each positive unit the Red Cross pulled from the system.
Source: AP Photo/Michael Conroy

An expensive screening program designed to keep the Zika virus out of the Red Cross’ blood supply has caught fewer than a dozen infected donations, a new study published Wednesday revealed.

The program, which costs roughly $137 million a year to operate, detected only eight units that tested positive for the virus between June 2016 and September 2017. And half of those units contained Zika

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks